CURRICULUM VITAE
INFORMAZIONI PERSONALI
Nome Andrea Pace
Data di nascita 2/8/1955
Qualifica Medico Chirurgo, Neurologo
Amministrazione IFO
Incarico attuale Responsabile UOSD Neuroncologia
Numero telefonico dell’ufficio 0652666067
Fax dell’ufficio 0652665068
E-mail istituzionale [email protected]
TITOLI DI STUDIO E
PROFESSIONALI ED ESPERIENZE
LAVORATIVE
Titolo di studio Laurea in Medicina e Chirurgia 26/7/1983 (Università la Sapienza
di Roma) con 110/110 e lode
Altri titoli di studio e professionali Specializzazione in Neurologia 24/7/1987 (Università la
Sapienza di Roma) con 70/70 e lode
Esperienze professionali ( incarichi
ricoperti)
Dal 1/5/2011 Istituto Nazionale Tumori Regina Elena
Responsabile SSD Neuroncologia
Dal 5/10/2009 Istituto Nazionale Tumori Regina Elena
Responsabile ff SSD Neurologia
Dal Maggio 2003 Responsabile della SSO di ambulatorio di
neuro-oncologia e assistenza continuativa domiciliare neuro-
oncologica
2001 ad oggi Corso di Laurea in Scienze infermieristiche
Università di Roma La Sapienza, Professore a contratto
1993 ad ottobre 2009 Istituto Nazionale Tumori Regina Elena –
Neurologo
1988-1993 IRCCS S Lucia di Roma Assistente medico neurologo
Capacità linguistiche Inglese, ottima conoscenza scritta e parlata
Capacità nell’uso delle tecnologie
Altro ( partecipazione a convegni e
seminari, pubblicazioni,
collaborazioni a riviste, ecc. ed
ogni altra informazione che il
Membro del Direttivo dell’Associazione Italiana di Neuro-
Oncologia
Membro del gruppo di studio SIN (Società Italiana Neurologia) di
Neuro-Oncologia
dirigente ritiene di dover
pubblicare)
Membro del gruppo di studio SIN di Bioetica
Socio SIN,SNO,SICP,AINO,EANO.
Member of editorial board of Neuroncology Journal
Member of editorial board of Neuroncology Practice Journal
Pubblicazioni su riviste recensite:
1-Pace A, Grassa C, Cavalletti C, Figa' Talamanca L: Complications of
cerebral angiography. Statistical analysis of 1260 cases. Recenti Prog
Med 1984 Feb;75(2):132-41
2-Bernardi S, Buttinelli C, Grasso MG, Millefiorini E, Pace A,
Prencipe M, Fieschi C.: Evolution and severity markers in 233 MS
patients. Riv Neurol. 1987 May-Jun;57(3):197-200.
3-Fieschi C, Argentino C, Lenzi GL, Fantozzi L, Sacchetti ML, Pace
A, Rasura M, Bastianello S, Bozzao L, Zanette E, et al. Therapeutic
window for pharmacological treatment in acute focal cerebral
ischemia. Ann N Y Acad Sci. 1988;522:662-6
4-Buttinelli C, Pace A, Mauriello A, Sette G, Bonanno E, Zanette EM.
B-mode echography in carotid pathology: correlation with
morphology. Minerva Med. 1988 Aug;79(8):665-7
5-Giubilei F, Argentino C, Silvestrini M, Pace A, Rasura M, Di Piero
V, Intiso D, Bastianello S, Paris L, Lenzi GL, et al.Prognostic factors
in acute cerebral infarct. Minerva Med. 1988 Aug;79(8):637-40.
6-Pietrangeli A, Finocchiaro R, Pace A, Rinaldi M, Jandolo B. The
effect of brain radiotherapy on the P3 component of ERP's. J
Neurosurg Sci. 1990 Jul-Dec;34(3-4):327-8.
7-Jandolo B, Pietrangeli A, Pace A, Carapella CM, Finocchiaro R,
Morace E.Brain-stem auditory evoked potentials in supratentorial brain
tumors. Electromyogr Clin Neurophysiol. 1992 Jun;32(6):307-9.
8-Grasso MG, Pantano P, Ricci M, Intiso DF, Pace A, Padovani A,
Orzi F, Pozzilli C, Lenzi GL. Mesial temporal cortex hypoperfusion is
associated with depression in subcortical stroke. Stroke. 1994
May;25(5):980-5.
9-Pace A., Pietrangeli A., Bove L., Rosselli M., Lopez M., Jandolo
B.:Neurotoxicity of antitumoral IL-2 therapy: evoked cognitive
potentials and brain mapping. Ital J Neurol Sci 15: 341-346, 1994.
10-Jandolo B., Della Giulia M., Pace A., Pietrangeli A. et al:
Neurophysiological examination of end-plate function in patients with
lung cancer. Electromyogr clin neurophysiol 35: 247-250, 1995.
11-Pietrangeli A., Bove L., Innocenti P., Pace A.:Meningiti
carcinomatose: aspetti clinici e decorso in 5 pazienti trattati con
metotrexate endorachide. Riv. Neurobiologia, 41(5), 671-675,1995.
12-Pace A., Jandolo B: Taxoids neurotoxicity. Neurology 47, 615,
1996.
13-Pace A., Bove L., Nisticò C, et al : Vinorelbine neurotoxicity:
clinical and neurophysiological findings in 23 patients. Journal of
Neurology, Neurosurgery and Psychiatry 61,4: 409-411, 1996.
14-Jandolo B., Pietrangeli A., Pace A. et al: Electrophysiological
testing in patients operated with the nerve sparing technique for
bladder and prostate. J Exp Clin Cancer Res 15: 67-70, 1996.
15-Fuoco U, Scivoletto G, Pace A, Vona VU, Castellano V. Anaemia
and serum protein alteration in patients with pressure ulcers. Spinal
Cord. 1997 Jan;35(1):58-60.
16-Pace A., Bove L., Aloe A, et al: Paclitaxel neurotoxicity: clinical
and neurophysiological study of 23 patients. Ital J Neurol Sci, 18:73-
79, 1997
17-Pace A., Innocenti P., Bove L., et al: Epilessia come sintomo di
esordio e nel decorso della malattia in 143 pazienti affetti da neoplasia
cerebrale emisferica. Boll Lega It Epil, 99:269-270, 1997.
18-Pietrangeli A., Bove L., Innocenti P., Pace A. et al:
neurophysiological evaluation of sexual dysfunction in patients
operated for colorectal cancer. Clinical Autonomic Research 8,6:353-
356, 1998
19-Pace A., Bove L., Innocenti P. et al: Epilepsy and gliomas:
Incidence and treatment in 119 patients. J Exp Clin Cancer Res, 17,4:
479-482, 1998
20-Pace A. Assistenza domiciliare neuro-oncologica. Il progetto
Qualità della vita dell’Istituto Regina Elena. Notiziario dei Comitati
Gigi Ghirotti. 1999
21-C.Nistico’, C.Garufi, M.Milella, A.Vaccaro, AM D’Ottavio,
A.Fabi, A.Pace, L.Bove, F.Tropea, A.Marsella, F.Izzo, RM D’Attimo,
V.Ferraresi, S.De Marco, E.Terzoli: Weekly schedule of vinorelbine in
pretreated breast cancer patients. Breast Cancer Research and
Treatment 59: 223-229, 2000
22-S.De Santis. A.Pace, L.Bove, F.Cognetti, F.Properzi, M.Fiore,
V.Triaca, A.Savarese, MD Simone, B.Jandolo, L.Manzione, L.Aloe:
Patients Treated with Antitumor Drugs Dispalying Neurological
Deficits Are Characterized by a Low Circulating Level of Nerve
Growth Factor Clinical Cancer Research 6, 90-95, January 2000
23-Bove L, Picardo M, Maresca V, Jandolo B, Pace A.: A Pilot study
on the relationship between cisplatin neuropathy and Vitamin. E. J Exp
Clin Cancer Res 2001; 20 (2): 277-280.
24-Pace A.: Cure palliative in Neuro-Oncologia. Notiziario dei
Comitati Ghirotti. Luglio/Settembre 2001.
25-Pompili A, Caperle M, Pace A, Ramazzotti V, Raus L, Jandolo B,
Occhipinti El: Quality of life evaluation in patients operated upon for
cerebellar pilocytic astrocytoma. J Neurosurgery 96:229-234, 2002
26-Pace A, Maschio M: Terapia Medica nei Gliomi di Basso Grado.
Neurol Sci 2002 23:s7-s9.
27-Pace A et al: Un modello di assistenza continuativa per malati con
tumore cerebrale. Rivista Italiana di Cure Palliative, vol 4 n 2, 2002.
28-Santanelli F, Tenna S, Pace A, Scuderi N: .Free flap reconstruction
of the sole of the foot with or without sensory nerve coaptation. Plast
Reconstr Surg. 2002 Jun;109(7):2314-22
29-Pace et al: Neuroprotective Effect of Vitamin E Supplementation in
Patients Treated With Cisplatin Chemotherapy. J Clin Oncol. 2003 Mar
1;21(5):927-31. 2003.
30-Leonetti C, Biroccio A, Gabellini C, Scarsella M, Maresca V, Flori
E, Bove L, Pace A, Stoppacciaro A, Zupi G, Cognetti F, Picardo M:
Alpha-tocopherol protects against cisplatin-induced toxicity without
interfering with antitumor efficacy. Int J Cancer. 2003 Mar
20;104(2):243-50.
31-Galie E, Pietrangeli A, Maschio M, Pace A, Vidiri A, Carosi M,
Jandolo B.: Demyelinating disease in monoclonal gammopathy of
undetermined significance. J Exp Clin Cancer Res. 2003
Jun;22(2):337-9.
32-Pace A, Vidiri A, Galie E, Carosi M, Telera S, Cianciulli AM,
Canalini P, Giannarelli D, Jandolo B, Carapella CM. Temozolomide
chemotherapy for progressive low-grade glioma: clinical benefits and
radiological response. Ann Oncol. 2003 ;14(12):1722-6.
33-Pace A.:Complicanze midollari iatrogene. Neurol Sci 2003;24.
34-Fabi A, Vidiri A, Carapella C, Pace A, Occhipinti E, Caroli F, Mirri
A, Carlini P, Cognetti F: Bone metastasis from glioblastoma
multiforme without central nervous system relapse: a case report.
Anticancer Research 24 2004
35- Reni M, Mason W, Zaja F, Perry J, Franceschi E, Bernardi D,
Dell'Oro S, Stelitano C, Candela M, Abbadessa A, Pace A, Bordonaro
R, Latte G, Villa E, Ferreri AJ. Salvage chemotherapy with
temozolomide in primary CNS lymphomas: preliminary results of a
phase II trial.European Journal of Cancer 2004 Jul;40(11):1682-8
36-Pace A, Pompili A: Depression in Patients with High-grade Glioma:
Results of the Glioma Project. Neurosurgery. 56(4):E873, April 2005.
37-Pace, Bove L, Jandolo B:Vitamin E and cisplatin neurotoxicity.
Neurology. 2005 Aug 9;65(3):501-2 l
38-Pace A: Diagnosi e trattamento delle Meningiti Neoplastiche.
Medicina & terapia. Supplemento 2005. Edimes
39- A. Pace:Neuropatie da farmaci:criteri diagnostici e
neuroprotezione. 2005;3:103-105.
40-Fabi A,Salesi N,Di Cocco B, Vidiri A, Visca P, Pace A, Carapella
C, De Paula U, Mirri A, Cognetti F: Choroid plexus carcinoma in the
adult: is there a role for chemotherapy? J Exp Clin Cancer Res.
2005;24(3):493-6.
41- PompiliA, Pace A, Occhipinti E: Subtemporal Transtentorial
Approach. J Neurosurgery 104; 854-855, 2006
42 -Maschio M, Albani F,Baruzzi A,ZarablaA,Dinapoli L,Pace
A,Pompili A,Carapella CM,Occhipinti E,Jandolo B: Levetiracetam
therapy in patients with brain tumour and epilepsy.
J Neurooncol 2006: 80(1):97-100
43-Guido Cavaletti, Stefano Jann, Andrea Pace, Rosaria Plasmati,
Gabriele Siciliano, Chiara Briani, Dario Cocito, Luca Padua, Elisabetta
Ghiglione, Mariagrazia Manicone, Giuditta Giussani, in the context of
the Italian NETox Group: Multi-center assessment of the Total
Neuropathy Score for chemotherapy-induced peripheral neurotoxicity.
J Peripher Nerv Syst. 2006 Jun;11(2):135-41.
44-Pace A, Fabi A: Chemotherapy in neoplastic meningitis. Critical
rewiev in Oncology/Hematology. 2006
45-Vidiri A, Carapella CM, Pace A, Mirri A, Fabi A, Carosi MA,
Giannarelli D, Pompili A, Jandolo E,Occhipinti E, Di Giovanni S,
Crecco M: Early post-operative MRI: correlation with progression free
survival and overall survival time in malignant gliomas. Journal of
Experimental and Clinical Cancer Research 2006:25 (2);177-182
46-G Cavaletti, B Frigeni, F Lanzani, M Piatti, S Rota, C Briani, G
Zara, R Plasmati, F Pastorelli, A Caraceni, A Pace, M Manicone, A
Lissoni, N Colombo, G Bianchi, C Zanna for the Italian NETox
Group: The Total Neuropathy Score as a useful assessment tool for
grading the course of chemotherapy-induced peripheral neurotoxicity:
a comparison with the National Cancer Institute-Common Toxicity
Scale. J Peripher Nerv Syst. 2007 Sep;12(3):210-5
47-M Reni, F Zaja, W Mason, J Perry, E Mazza, M Spina, R
Bordonaro, F Ilariucci, M Faedi, G Corazzelli, P Manno, E Franceschi,
A Pace, M Candela, A Abbadessa, C Stelitano, G Latte and A J M
Ferreri: Temozolomide as salvage treatment in primary brain
lymphomas British Journal of Cancer (2007) 96, 864-867.
48-Andrea Pace, Cecilia Nisticò, Federica Cuppone, Emilio Bria,
Edvina Galiè,Giuliana Graziano, Guido Natoli, Isabella Sperduti,
Bruno Jandolo, Francesca Calabretta, Silverio Tomao, Edmondo
Terzoli:Peripheral Neurotoxicity of Weekly Paclitaxel Chemotherapy:
A Schedule or a Dose Issue? Clin Breast Cancer. 2007 Apr;7(7):550-4
49-Andrea Pace: Intrathecal chemotherapy treatment of neoplastic
meningitis from solid tumors using liposomal cytarabine: experience at
the Istituto Regina Elena di Roma. Tumori, 93 (3);9-12:2007
50-A Pace:Supportive care and end of life issues. Rivista Medica.
2007,vol 13 n 4
51-Pace A. Rehabilitation in brain tumor patients. J Exp Clin canc
Res,26,3,2007
52- Maschio M, Dinapoli L, Zarabla A, Pompili A, Carapella CM,
Pace A, Giannarelli D, Occhipinti E, Jandolo B: Outcome and
tolerability of topiramate in brain tumor associated epilepsy.. J
Neurooncol; 2007, 86(1): 61-70.
53- Nisticò C, Bria E, Cuppone F, Fornier M, Sperduti I, Carpino A,
Pace A, Cognetti F, Terzoli E.
Weekly epirubicin and paclitaxel with granulocyte colony-stimulating
factor support in previously untreated metastatic breast cancer patients:
a phase II study. Anticancer Drugs. 2007 Jul;18(6):687-92.
54-Andrea Pace, Cristiano Parisi, Maurizio Di Lelio. La Riabilitazione
palliativa. Un progetto per l’assistenza e la qualità della vita dei malati
neuro-oncologici. Riabilitazione Oggi. Anno XXIV, settembre 2007,
52-53
55- Fabi A, Mirri A, Felici A, Vidiri A, Pace A, Occhipinti E, Cognetti
F, Arcangeli G, Iandolo B, Carosi MA, Metro G, Carapella CM.Fixed
dose-rate gemcitabine as radiosensitizer for newly diagnosed
glioblastoma: a dose-finding study. J Neurooncol. 2008 Mar;87(1):79-
84 IF 3.115
56-Pompili A, Telera S, Pace A:Metastases to the cerebellum. Results
and prognostic factors in a consecutive series of 44 operated patients. J
Neurooncol. 2008 Jul;88(3):331-7 IF 3.115
57- Maschio M, Albani F, Jandolo B, Zarabla A, Contin M, Dinapoli
L, Fabi A, Pace A, Baruzzi A:
Temozolomide treatment does not affect topiramate and oxcarbazepine
plasma concentrations in chronically treated patients with brain tumor-
related epilepsy. J Neurooncol. 2008 Nov;90(2):217-21 IF 3.115
58-Andrea Pace, Cherubino Di Lorenzo, Lara Guariglia, B Jandolo,
Carmine M Carapella, Alfredo Pompili: End of life issues in brain
tumor patients. J Neurooncol. 2009 Jan;91(1):39-43 IF 3.115
59-Anna Maria Di Nallo, Antonello Vidiri, Simona Marzi, Alessandra
Mirri, Alessandra Fabi, Carmine Maria Carapella, Andrea Pace and
Marcello Crecco: Quantitative analysis of CT-perfusion parameters in
the evaluation of brain gliomas and metastases. Journal of
Experimental & Clinical Cancer Research 2009, 28:38 IF 3.07
60-Alessandra Fabi, Giulio Metro, Michelangelo Russillo, Antonello
Vidiri, Carmine M Carapella, Marta Maschio, Francesco Cognetti,
Bruno Jandolo, Maria A Mirri, Isabella Sperduti, Stefano Telera,
Mariantonia Carosi and Andrea Pace: Treatment of recurrent malignant
gliomas with fotemustine monotherapy: impact of dose and correlation
with MGMT promoter methylation BMC Cancer 2009, 9:101IF 3.33
61- Maschio M, Dinapoli L, Vidiri A, Pace A, Fabi A, Pompili A,
Carapella MC, Jandolo B.:The role side effects play in the choice of
antiepileptic therapy in brain tumor-related epilepsy: a comparative
study on traditional antiepileptic drugs versus oxcarbazepine J Exp
Clin Cancer Res. 2009 May 6;28:60. IF 3.07
62 - Dinapoli L, Maschio M, Jandolo B, Fabi A, Pace A, Sperati F,
Muti P.:Quality of life and seizure control in patients with brain tumor-
related epilepsy treated with levetiracetam monotherapy: preliminary
data of an open-label study. Neurol Sci. 2009 May 5. I.F. 1.22
63 - Cavaletti G, Cornblath DR, Postma TJ, Merkies IS, Argyriou A,
Boogerd W, Briani C, Bruna J, Faber CG, Grisold W, Heimans JJ,
Kalofonos H, Krarup-Hansen A, Koeppen S, Lauria G, Leandri M,
Mielke S, Nobile-Orazio E, Pace A, Padua L, Plasmati R, Psimaras D,
Ros T, Schenone A, Stragliotto G, Galimberti S, Valsecchi MG. CI-
PERINOMS Study Group: CI-PERINOMS: chemotherapy-induced
peripheral neuropathy outcome measures study. J Peripher Nerv Syst.
2009 Jun;14(2):69-71. IF 2.57
64-Pace A, Di Lorenzo C, Guariglia L, Zaratti M: Complicanze
neurologiche in oncologia. Clinical Management Issues 2010;4 (1)
49:56
65-Pace A, Giannarelli D, Galiè E, Savarese A, Carpano S, Della
Giulia M, Pozzi A, Silvani A, Gaviani P, Scaioli V, Jandolo B, Bove L,
Cognetti F. Vitamin E neuroprotection for cisplatin neuropathy: A
randomized, placebo-controlled trial. Neurology. 2010 Mar
2;74(9):762-6. IF 8.25
66- Metro G, Fabi A, Mirri MA, Vidiri A, Pace A, Carosi M, Russillo
M, Maschio M,
Giannarelli D, Pellegrini D, Pompili A, Cognetti F, Carapella CM.
Phase II study of fixed dose rate gemcitabine as radiosensitizer for
newly diagnosed glioblastoma multiforme. Cancer Chemother
Pharmacol. 2010 Jan;65(2):391-7. Epub 2009 Oct 22. IF 2.795
67-Alessandra Fabi, Giulio Metro, Antonello Vidiri, Gaetano Lanzetta,
Mariantonia Carosi, Stefano Telera, Marta Maschio, Michelangelo
Russillo , Isabella Sperduti, Carmine M. Carapella, Francesco Cognetti,
Andrea Pace. Low-dose fotemustine for treatment of recurrent
malignant glioma: a multicenter phase II study. J Neurooncol 2010 IF
3.115
68 -Pace A et al:Come ottimizzare le terapie orali in neuroncologia.
THERAPY PERSPECTIVES Anno XII, N. XX, maggio 2010
69-Pace A, Metro G, Fabi A: Supportive care in neurooncology.
Current Opinion in Oncology 2010 IF 4.027
70- Maschio M, Dinapoli L, Sperati F, Pace A, Fabi A, Vidiri A, Muti
P. Levetiracetam monotherapy in patients with brain tumor-related
epilepsy: seizure control, safety, and quality of life. J Neurooncol.
2011 Aug;104(1):205-14 IF 3.115
71-Fabi A, Felici A, Metro G, Mirri A, Bria E, Telera S, Moscetti L,
Russillo M,
Lanzetta G, Mansueto G, Pace A, Maschio M, Vidiri A, Sperduti I,
Cognetti F, Carapella CM. Brain metastases from solid tumors: disease
outcome according to type of treatment and therapeutic resources of
the treating center. J Exp Clin Cancer Res. 2011 Jan 18;30:10 IF 3.07
72-Vidiri A, Guerrisi A, Pinzi V, Fabi A, Mirri MA, Pompili A,
Caporale N, Pace A, Crecco M, Marzi S. Perfusion Computed
Tomography (PCT) adopting different perfusion metrics: Recurrence
of brain metastasis or radiation necrosis? Eur JRadiol. 2011 Mar 30. IF
2.645
73-Maschio M, Dinapoli L, Mingoia M, Sperati F, Pace A, Pompili A,
Carapella CM, Vidiri A, Muti P. Lacosamide as add-on in brain tumor-
related epilepsy: preliminary report on efficacy and tolerability. J
Neurol. 2011 Jun 16. IF 3.578
74- Pace A: Pain treatment as a human right. World Neurology 26;3,
2011
75-Pace A. Epilepsy, supportive care and cognitive rehabilitation.
Rivista Medica 2011; 17 (suppl 1), 50-59
76-Maschio M, Dinapoli L, Sperati F, Fabi A, Pace A, Vidiri A, Muti
P.Oxcarbazepine monotherapy in patients with brain tumor-related
epilepsy:open-label pilot study for assessing the efficacy, tolerability
and impact on quality of life. J Neurooncol. 2011 Aug 17. IF 3.115
77-Maschio M, Dinapoli L, Fabi A, Pace A, Vidiri A, Muti P. Eritema
multiforme durante radioterapia in 4 pazienti con epilessia secondaria
a neoplasia cerebrale in monoterapia con oxcarbazepina. Boll Lega
It Epil. 2011: 142;167-9
78-Michelangelo Bartolo, Chiara Zucchella, Andrea Pace, Gaetano
Lanzetta, Carmine Vecchione, Marcello Bartolo, Giovanni Grillea,
Mariano Serrao, Francesco Pierelli, Cristina Tassorelli, Giorgio
Sandrini: Early rehabilitation after surgery improves functional
outcome in brain tumors inpatients. J Neurooncol 2012
May;107(3):537-44 IF 3.115
79- The chemotherapy-induced peripheral neuropathy outcome
measure standardization (CI-PERINOMS) study: an answer to the
unsettled question of drug-related neuropathy assessment in cancer
patients. The CI-PERINOMS Study Group. EANO Magazine 2011; 2
(1), 37-39
80- Pace A, Di Lorenzo C, A Capon, V Villani, D Benincasa, Guariglia
L, M Salvati, C Brogna, V Mantini, Padovan A, Mastromattei, Pompili
A: Quality of care and rehospitalization rate in the last stage of disease
in malignant gliomas assisted at home: a cost effectiveness study J
Palliat Med. 2012 Feb;15(2):225- IF 1.891
81 -Antonello Vidiri, Andrea Pace, Alessandra Fabi, Marta Maschio,
Gaetano Marco Latagliata, Vincenzo Anelli, Francesca Piludu,
Carmine Maria Carapella, Giuseppe Giovinazzo and Simona Marzi:
Early perfusion changes in patients with recurrent high-grade brain
tumor treated with Bevacizumab: preliminary results by a quantitative
evaluation Journal of Experimental & Clinical Cancer Research 2012,
Apr 11;31(1):33-7 IF 3.07
82 Chiara Zucchella , Andrea Pace , Francesco Pierelli , Michelangelo
Bartolo. Riabilitazione cognitiva in pazienti neuro-oncologici: tre casi
clinici. Clinical Management Issues 2012; 6(2); 67-73
83 Cavaletti G, Cornblath DR, Merkies ISJ, Postma TJ, Rossi E,
Frigeni B, Alberti P, Bruna J, Velasco R, Argyriou AA, Kalofonos HP,
Psimaras D, Ricard D, Pace A, Galiè E., Briani C, Dalla Torre C
,Faber CG, Lalisang RI, Boogerd W, Brandsma D, Koeppen S, Hense
J, Storey D, Kerrigan S, Schenone A, Fabbri. S, Valsecchi MG and the
CI-PeriNomS Group (*)
The Chemotherapy-Induced Peripheral Neuropathy Outcome Measures
Standardization (CI-PeriNomS) study: from consensus to the first
validity and reliability findings. Annals of Oncology 2013 24(2):454-
62. IF 6.425
84 Pace A, Di Lorenzo C, Villani V, Guariglia L, Maschio M, Pompili
A, Carapella CM. Epilepsy at the end of life in malignant gliomas. J
Neuro-oncology. 2013 Jan;111(1):83-6. IF 3.115
85 Andrea Pace, Edvina Galiè, Tatiana Koudriavtseva.Neuroprotective
strategies in the prevention of chemotherapy-induced neuropathies. J of
Supportive Care in Cancer. Support Care Cancer. 2013 Jan;21(1):1-2
IF 2.649
86 Pace A, Villani V Extra-Cranial Metastases from Glioblastoma
Multiforme. EANO Magazine 2012
87 Andrea Pace, Veronica Villani, Chiara Zucchella, Marta Maschio
Quality of Life of Brain Tumour Patients EANO Magazine 2012
88 Michelangelo Bartolo, Chiara Zucchella, Andrea Pace, Alessandro
M De Nunzio, Mariano Serrao, Giorgio Sandrini and Francesco
Pierelli. Improving neuro-oncological patients care: basic and practical
concepts for nurse specialist in neuro-rehabilitation. Journal of
Experimental & Clinical Cancer Research 2012, 31:82 IF 3.07
89 Dinapoli, L., Maschio, M., Mingoia, M., Sperati, F., Fabi, A., Pace,
A., Petreri, G., Muti, P. Add-on lacosamide in brain tumor-related
epilepsy. Preliminary report: Efficacy and tolerability | Lacosamide
come antiepilettico in add-on in pazienti affetti da epilessia secondaria
a tumore cerebrale (2012) Bollettino - Lega Italiana contro l'Epilessia
(144) PP. 195 - 197
90 Maschio M, Dinapoli L, Sperati F, Pace A, Fabi A, Vidiri A,
Pompili A, Carapella CM. Effect of pregabalin add-on treatment on
seizure control, quality of life, and anxiety in patients with brain
tumour-related epilepsy: a pilot study. Epileptic Disord. 2012
14(4):388-97.
91 Graceffa D, Maiani E, Pace A, Solivetti FM, Elia F, De Mutiis C,
Bonifati C. Psoriatic Arthritis during Treatment with Bevacizumab for
Anaplastic Oligodendroglioma. Case Report Rheumatol.
2012;2012:208606. doi: 10.1155/2012/208606. Epub 2012 Nov 29
92 Chiara Zucchella, Michelangelo Bartolo, Cherubino Di Lorenzo,
Veronica Villani, Andrea Pace, Cognitive impairment in primary brain
tumors outpatients: a prospective cross-sectional survey. J Neuro
Oncology, 2013 112(3):455-60. IF 3.115
93 Telera S, Fabi A, Pace A, Vidiri A, Anelli V, Carapella CM,
Marucci L, Crispo F, Sperduti I, Pompili A. Radionecrosis induced by
stereotactic radiosurgery of brain metastases: results of surgery and
outcome of disease. J Neurooncol. 2013 Mar 25. IF 3.115
94 Binda D, Vanhoutte EK, Cavaletti G, Cornblath DR, Postma TJ,
Frigeni B, Alberti P, Bruna J, Velasco R, Argyriou AA, Kalofonos HP,
Psimaras D, Ricard D, Pace A, Galiè E, Briani C, Dalla Torre C,
Lalisang RI, Boogerd W, Brandsma D, Koeppen S, Hense J, Storey D,
Kerrigan S, Schenone A, Fabbri S, Rossi E, Valsecchi MG, Faber CG,
Merkies IS; CI-PeriNomS study group. Rasch-built Overall Disability
Scale for patients with chemotherapy-induced peripheral neuropathy
(CIPN-R-ODS). Eur J Cancer. 2013 May 10 IF 5.3
95 Salmaggi A, Simonetti G, Trevisan E, Beecher D, Carapella CM,
Dimeco F, Conti L, Pace A, Filippini G. Perioperative
thromboprophylaxis in patients with craniotomy for brain tumours: a
systematic review. J Neurooncol. 2013 113(2):293-303. IF 3.115
96 Zucchella C, Capone A, Codella V, De Nunzio AM, Vecchione C,
Sandrini G, Pace
A, Pierelli F, Bartolo M. Cognitive rehabilitation for early post-surgery
inpatients affected by primary brain tumor: a randomized, controlled
trial. J Neurooncol. 2013 May 16. IF 3.115
98 P. Alberti, E. Rossi, D. R. Cornblath, I. S. J. Merkies, T. J. Postma,
B. Frigeni, J. Bruna, R. Velasco, A. A. Argyriou, H. P. Kalofonos, D.
Psimaras, D. Ricard, A. Pace, E. Galiè, C. Briani, C. Dalla Torre, C. G.
Faber, R. I. Lalisang, W. Boogerd, D. Brandsma, S. Koeppen, J. Hense,
D. Storey1, S. Kerrigan, A. Schenone, S. Fabbri, M. G. Valsecchi, G.
Cavaletti and the CI-PeriNomS Group (**) Physician-assessed and
patient-reported outcome measures in chemotherapy-induced sensory
peripheral neurotoxicity: two sides of the same coin. Annals of
Oncology 2014 Jan;25(1):257-64 IF 6.425
99 Andrea Pace, Veronica Villani, Dario Benincasa, Antonella Di
Pasquale. Palliative and supportive care in neuro-oncology. Review in
Oncology 2013
100 Minniti G, Arcella A, Scaringi C, Lanzetta G, Di Stefano D,
Scarpino S, Pace A, Giangaspero F, Osti MF, Enrici RM.
Chemoradiation for anaplastic oligodendrogliomas: clinical outcomes
and prognostic value of molecular markers. J Neurooncol. 2014
Jan;116(2):275-82. IF 3.115
101 A Pace, V Villani, A Di Pasquale, D Benincasa, L Guariglia, S
Ieraci, S Focarelli, CM Carapella and A Pompili . Home care for brain
tumour patients. Neurooncology Practice 2013
102 Maschio, M., Dinapoli, L., Fabi, A., Pace, A., Giannarelli, D. The
importance of a cognitive rehabilitation program in patients with brain
tumor-related epilepsy and cognitive deficits | L'importanza di un
percorso di riabilitazione cognitiva nel paziente con epilessia tumorale
con deficit neurocognitivi (2013) Bollettino - Lega Italiana contro
l'Epilessia (145) PP. 55 - 58
103 Johan A.F. Koekkoek, Linda Dirven, Jaap C. Reijneveld, Tjeerd J.
Postma, Robin Grant, Andrea Pace, Stefan Oberndorfer, Jan J.
Heimans, Martin J.B. Taphoorn Epilepsy in the end of life phase of
brain tumor patients: a systematic review Neurooncology Practice 2014
104 Griffith KA, Dorsey SG, Renn CL, Zhu S, Johantgen ME,
Cornblath DR, Argyriou AA, Cavaletti G, Merkies IS, Alberti P,
Postma TJ, Rossi E, Frigeni B, Bruna J, Velasco R, Kalofonos HP,
Psimaras D, Ricard D, Pace A, Galie E, Briani C, Torre CD, Faber CG,
Lalisang RI, Boogerd W, Brandsma D, Koeppen S, Hense J, Storey DJ,
Kerrigan S, Schenone A, Fabbri S, Valsecchi MG; the CI-PeriNomS
Group. Correspondence between neurophysiological and clinical
measurements of chemotherapy-induced peripheral neuropathy:
secondary analysis of data from the
CI-PeriNoms study. J Peripher Nerv Syst. 2014 May 10
105 Minniti G, Scaringi C, Arcella A, Lanzetta G, Di Stefano D,
Scarpino S, Bozzao A, Pace A, Villani V, Salvati M, Esposito V,
Giangaspero F, Enrici RM. IDH1 mutation and MGMT methylation
status predict survival in patients with anaplastic astrocytoma treated
with temozolomide-based chemoradiotherapy. J Neurooncol. 2014 Apr
20. [Epub ahead of print
106 Maschio M, Sperati F, Dinapoli L, Vidiri A, Fabi A, Pace A,
Pompili A, Carapella CM, Cantelmi T. Weight of epilepsy in brain
tumor patients. J Neurooncol. 2014 Jun;118(2):385-93
107 V. Vaccaro,1 A. Fabi,1 A. Vidiri,2 D. Giannarelli,3 G. Metro,4 S.
Telera,5 S. Vari,1 F. Piludu,2 M. A. Carosi,6 V. Villani,7 F. Cognetti,1
A. Pompili,5 L. Marucci,8 C. M. Carapella,5 and A.Pace7 Activity and
Safety of Bevacizumab Plus Fotemustine for Recurrent Malignant
Gliomas BioMed Research International Volume 2014, Article ID
351252, 7 pages
108 Lombardi G, Della Puppa A, Di Stefano AL, Pace A, Rudà R,
Tabouret E, Zagonel V. Gliomas. Biomed Res Int. 2014;2014:470523.
Epub 2014 Aug 26.
109 Pompili A, Telera S, Villani V, Pace A. Home palliative care and
end of life issues in glioblastoma multiforme: results and comments
from a homogeneous cohort of patients. Neurosurg Focus. 2014
Dec;37(6):E5.
110 Minniti G, Scaringi C, Lanzetta G, Terrenato I, Esposito V,
Arcella A, Pace A, Giangaspero F, Bozzao A, Enrici RM. Standard
(60 Gy) or Short-Course (40 Gy) Irradiation Plus Concomitant and
Adjuvant Temozolomide for Elderly Patients With Glioblastoma: A
Propensity-Matched Analysis. Int J Radiat Oncol Biol Phys. 2015 Jan
1;91(1):109-15.
111 Chiaravalloti A, Fiorentini A, Villani V, Carapella C, Pace A, Di
Pietro B, Di Russo C, Palumbo B, Floris R, Schillaci O. Factors
affecting ¹⁸F FDOPA standardized uptake value in patients with
primary brain tumors after treatment. Nucl Med Biol. 2015
Apr;42(4):355-9.
112 Villani V, Casini B, Pace A, Prosperini L, Carapella CM, Vidiri A,
Fabi A, Carosi M. The Prognostic Value of Pyrosequencing-Detected
MGMT Promoter Hypermethylation in Newly Diagnosed Patients with
Glioblastoma. Dis Markers. 2015;2015:604719. doi:
10.1155/2015/604719. Epub 2015 Aug 11.
113 Piludu F, Marzi S, Pace A, Villani V, Fabi A, Carapella CM,
Terrenato I, Antenucci A, Vidiri A. Early biomarkers from dynamic
contrast-enhanced magnetic resonance imaging to predict the response
to antiangiogenic therapy in high-grade gliomas. Neuroradiology. 2015
Sep 12. [Epub ahead of print]
114 Villani V, Carapella CM, Chiaravalloti A, Terrenato I, Piludu F,
Vidiri A,Schillaci O, Floris R, Marzi S, Fabi A, Pace A. The Role of
PET [18F]FDOPA in Evaluating Low-grade Glioma. Anticancer Res.
2015 Sep;35(9):5117-22. PubMed PMID:
26254416.
115 Lombardi G, Pace A, Pasqualetti F, Rizzato S, Faedi M, Anghileri
E, Nicolotto E, Bazzoli E, Bellu L, Villani V, Fabi A, Ferrazza P,
Gurrieri L, Dall'Agata M, Eoli M, Della Puppa A, Pambuku A,
D'Avella D, Berti F, Rudà R, Zagonel V. Predictors of survival and
effect of short (40 Gy) or standard-course (60 Gy)irradiation plus
concomitant temozolomide in elderly patients with glioblastoma: a
multicenter retrospective study of AINO (Italian Association of Neuro-
Oncology). J Neurooncol. 2015 Nov;125(2):359-67
116 Walbert T, Pace A. End-of-life care in patients with primary
malignant braintumors: early is better. Neuro Oncol. 2016 18 (1), pp.
7-8.
117 Binda D, Cavaletti G, Cornblath DR, Merkies IS; CI-PeriNomS
study group.Rasch-Transformed Total Neuropathy Score clinical
version (RT-TNSc(©) ) in patients with chemotherapy-induced
peripheral neuropathy. J Peripher Nerv Syst. 2015 Sep;20(3):328-32.
doi: 10.1111/jns.12140.
118 Villani V, Zucchella C, Cristalli G, Galiè E, Bianco F, Giannarelli
D, Carpano S, Spriano G, Pace AVitamin E neuroprotection against
cisplatin ototoxicity: preliminary results from a randomised, placebo-
controlled trial. Head and Neck, 2016 Apr;38 Suppl 1:E2118-21
119 Pace A, Villani V, Parisi C, Di Felice S, Lamaro M, Falcicchio C,
Bonucci A,Pugliese P, di Napoli A, Di Lallo D. Rehabilitation
pathways in adult brain tumor patients in the first 12 months of disease.
A retrospective analysis of services utilization in 719 patients. Support
Care Cancer. 2016 Jul 15. [Epub ahead of
120 Andrea Pace, Dario Benincasa and Veronica Villani. Trigger
symptoms at the end of life in brain tumor patients. WFNO Magazine
2016
121 Cordone I, Masi S, Carosi M, Vidiri A, Marchesi F, Marino M,
Telera S, Pasquale A, Mengarelli A, Conti L, Pescarmona E, Pace A,
Carapella CM. Brain stereotactic biopsy flow cytometry for central
nervous system lymphoma characterization: advantages and pitfalls. J
Exp Clin Cancer Res. 2016 Aug 27;35(1):128. doi: 10.1186/s13046-
016-0404-1.
122 Bartolo M, Chiò A, Ferrari S, Tassorelli C, Tamburin S, Avenali
M, Azicnuda E, Calvo A, Caraceni AT, Defazio G, DE Icco R,
Formisano R, Franzoni S, Greco E, Jedrychowska I, Magrinelli F,
Manera U, Marchioni E, Mariotto S, Monaco S, Pace A, Saviola D,
Springhetti I, Tinazzi M, DE Tanti A; Italian Consensus Conference on
Pain in Neurorehabilitation (ICCPN). Assessing and treating pain in
movement disorders, amyotrophic lateral sclerosis, severe acquired
brain injury, disorders of consciousness, dementia, oncology and
neuroinfectivology Eur J Phys Rehabil Med. 2016 Aug 31. [Epub
ahead of print]
123 Veronica Villani, Roberta Merola, Antonello Vidiri, Alessandra
Fabi, Mariantonia Carosi, Diana Giannarelli, Laura Marucci,
Marta
Maschio MD, Carmine M Carapella,
Andrea Pace. Temozolomide low
dose chemotherapy in newly diagnosed low grade gliomas: activity,
safety and long term follow up Tumori Journal 2016
124 Galié E, Renna R, Plantone D, Pace A, Marino M, Jandolo B,
Koudriavtseva T. Paraneoplastic Morvan's syndrome following
surgical treatment of recurrent thymoma: A case report. Oncol Lett.
2016 Oct;12(4):2716-2719.
125 Castelnuovo G, Giusti EM, Manzoni GM, Saviola D, Gatti A,
Gabrielli S, Lacerenza M, Pietrabissa G, Cattivelli R, Spatola CA,
Corti S, Novelli M, Villa V, Cottini A, Lai C, Pagnini F, Castelli L,
Tavola M, Torta R, Arreghini M, Zanini L, Brunani A, Capodaglio P,
D'Aniello GE, Scarpina F, Brioschi A, Priano L, Mauro A, Riva G,
Repetto C, Regalia C, Molinari E, Notaro P, Paolucci S, Sandrini G,
Simpson SG, Wiederhold B, Tamburin S. Psychological Treatments
and
Psychotherapies in the Neurorehabilitation of Pain: Evidences and
Recommendations from the Italian Consensus Conference on Pain in
Neurorehabilitation. Front Psychol. 2016 Feb 19;7:115. doi:
10.3389/fpsyg.2016.00115. Review. PubMed PMID: 26924998;
PubMed Central PMCID: PMC4759289.
126 Castelnuovo G, Giusti EM, Manzoni GM, Saviola D, Gatti A,
Gabrielli S, Lacerenza M, Pietrabissa G, Cattivelli R, Spatola CA,
Corti S, Novelli M, Villa V, Cottini A, Lai C, Pagnini F, Castelli L,
Tavola M, Torta R, Arreghini M,Zanini L, Brunani A, Capodaglio P,
D'Aniello GE, Scarpina F, Brioschi A, Priano L, Mauro A, Riva G,
Repetto C, Regalia C, Molinari E, Notaro P, Paolucci S, Sandrini G,
Simpson SG, Wiederhold B, Tamburin S. Psychological
Considerations in the Assessment and Treatment of Pain in
Neurorehabilitation and Psychological Factors Predictive of
Therapeutic Response: Evidence and Recommendations from the
Italian Consensus Conference on Pain in Neurorehabilitation. Front
Psychol. 2016 Apr 19;7:468. doi: 10.3389/fpsyg.2016.00468. Review.
PubMed PMID: 27148104; PubMed Central PMCID: PMC4835496.
127 Porro CA, Sandrini G, Truini A, Tugnoli V, Alfonsi E, Berliocchi
L, Cacciatori C, LA Cesa S, Magrinelli F, Sacerdote P, Valeriani M,
Tamburin S. Diagnosing and assessing pain in neurorehabilitation:
from translational research to the clinical setting. Evidence and
recommendations from the Italian Consensus Conference on Pain in
Neurorehabilitation. Eur J Phys Rehabil Med. 2016 Oct;52(5):717-729.
PubMed PMID: 27579580.
128 Tamburin S, Lacerenza MR, Castelnuovo G, Agostini M, Paolucci
S, Bartolo M, Bonazza S, Federico A, Formaglio F, Giusti EM,
Manzoni GM, Mezzarobba S, Pietrabissa G, Polli A, Turolla A,
Sandrini G; Italian Consensus Conference on Pain in
Neurorehabilitation (ICCPN). Pharmacological and non-
pharmacological strategies in the integrated treatment of pain in
neurorehabilitation. Evidence and recommendations from the Italian
Consensus Conference on Pain in Neurorehabilitation. Eur J Phys
Rehabil Med. 2016 Oct;52(5):741-752. PubMed PMID:
27579583.
129 Sandrini G, Tamburin S, Paolucci S, Boldrini P, Saraceni VM,
Smania N; Italian Consensus Conference on Pain in
Neurorehabilitation (ICCPN).. Time for a Consensus Conference on
pain in neurorehabilitation. Eur J Phys Rehabil Med. 2016
Oct;52(5):714-716. PubMed PMID: 27406655.
130 Tamburin S, Paolucci S, Magrinelli F, Musicco M, Sandrini G.
The Italian Consensus Conference on Pain in Neurorehabilitation:
rationale and methodology. J Pain Res. 2016 May 30;9:311-8. doi:
10.2147/JPR.S84646. PubMed PMID: 27313474; PubMed Central
PMCID: PMC4892860
131 Iole Cordone, Serena Masi,
Valentina Summa, Mariantonia Carosi,
Antonello Vidiri, Alessandra Fabi,
Alessia Pasquale, Laura Conti,
Immacolata Rosito, Carmine Maria Carapella, Veronica Villani and
Andrea Pace Over-expression of Syndecan-1, MUC-1 and stem cell
markers in breast cancer neoplastic meningitis: a cerebrospinal
fluid flow cytometry study. Breast Cancer res. Breast Cancer Res.
2017 Apr 11;19(1):46. doi: 10.1186/s13058-017-0827-4.
132 Russo M, Villani V, Taga A, Genovese A, Terrenato I, Manzoni
GC, Servadei F, Torelli P, Pace A. Headache as a presenting symptom
of glioma: A cross-sectional study. Cephalalgia. 2017 Jan
1:333102417710020.
133 Andrea Pace, Linda Dirven, Johan AF Koekkoek, Heidrun Golla,
Jane Fleming, , Roberta Rudà, Christine Marosi, Emilie Le Rhun,
Robin Grant, Kathy Oliver, Ingela Oberg, Helen J Bulbeck, Alasdair G
Rooney, Roger Henriksson, H Roeline W Pasman, Stefan Oberndorfer,
Michael Weller, Martin JB Taphoorn, on behalf of the European
Association of Neuro-Oncology palliative care task force. EANO
guidelines for palliative care in adult glioma patients. Lancet Oncol.
2017 Jun;18(6):e330-e340
134 Kieffer JM, Postma TJ, van de Poll-Franse L, Mols F, Heimans JJ,
Cavaletti G, Aaronson NK; CI-PeriNomS Group. Evaluation of the
psychometric properties of the EORTC chemotherapy-induced
peripheral neuropathy questionnaire (QLQ-CIPN20). Qual Life Res.
2017 Jun 20. doi: 10.1007/s11136-017-1626-1. [Epub ahead of
print]PubMed PMID: 28634676. IF 2.99
136 Clausola di coscienza e cura nell’assistenza al fine vita
LUDOVICA DE PANFILIS1, DANIELA CATTANEO, LUISANNA
COLA, MADDALENA GASPARINI, CORINNA PORTERI,
DANIELA TARQUINI, ALESSANDRO TIEZZI, SIMONE
VERONESE, SILVIA ZULLO, EUGENIO PUCCI, PER IL GRUPPO
DI STUDIO IN BIOETICA E CURE PALLIATIVE DELLA
SOCIETÀ ITALIANA DI NEUROLOGIA*. Recenti Prog Med 2017;
108: 216-220
3/7/2017